• Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 11 Jan 2025 01:46:14   America/Chicago


    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat January 11, 2025 Share Link copied to clipboard. Arrowhead Pharmaceuticals, Inc.
    Read more...
Share on,